RxDoctor Payments Data

Mary Bertossi

Pediatrics · Atlanta, GANPI 1649630310

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Tolmar, Inc. at 31.4% of the total. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,307in general payments, 2019–2025

Across 443 payments — averaging $45.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar, Inc.$6K
  • Novo Nordisk AS$5K
  • Novo Nordisk$1K
  • Pfizer$974
  • AbbVie$950
  • Xeris Pharmaceuticals, Inc.$706
  • plus $5K from 40 others

What the payments were for

  • Consulting fees$8,77043%
  • Speaking & faculty fees$6403%
  • Travel & lodging$1,7759%
  • Food & beverage$9,12245%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,307 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia

Other pediatrics in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →